Pacific Biosciences of California Inc. sell StockNews.com
Start price
18.04.24
/
50%
€1.39
Target price
18.04.25
-
Performance (%)
-27.05%
End price
19.04.25
€1.01
Summary
This prediction ended on 19.04.25 with a price of €1.01. The price of Pacific Biosciences of California Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -27.05%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | -16.926% | -16.926% | -2.066% |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.78
15.02.25
15.02.25
-
15.02.26
15.02.26
-16.80%
16.02.26
16.02.26
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.86
12.03.24
12.03.24
-
12.03.25
12.03.25
-69.22%
13.03.25
13.03.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.85
13.01.24
13.01.24
-
13.01.25
13.01.25
-65.82%
14.01.25
14.01.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€9.37
29.12.23
29.12.23
-
29.12.24
29.12.24
-80.02%
30.12.24
30.12.24